CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
Birmingham, Alabama, United States and 9 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Birmingham, Alabama, United States and 131 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Homewood, Alabama, United States and 29 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Birmingham, Alabama, United States and 388 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...
Phase 3
Homewood, Alabama, United States and 271 other locations
prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...
Phase 3
Birmingham, Alabama, United States and 538 other locations
The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned t...
Phase 3
Birmingham, Alabama, United States and 559 other locations
The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...
Phase 3
Birmingham, Alabama, United States and 320 other locations
The purpose of this study is to determine if the addition of apalutamide to ADT provides superior efficacy in improving radiographic progression-free...
Phase 3
Homewood, Alabama, United States and 228 other locations
The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progre...
Phase 3
Birmingham, Alabama, United States and 255 other locations
Clinical trials
Research sites
Resources
Legal